Journal
METABOLITES
Volume 13, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/metabo13030345
Keywords
glucose; cancer; cancer treatment; metabolism
Categories
Ask authors/readers for more resources
Cancer cells reprogram their metabolism to support their growth and survival. Reprogrammed glucose metabolism promotes key characteristics of cancer and enzymes involved in glycolysis can be targeted for anti-cancer treatments. This review summarizes the role of reprogrammed glucose metabolism in cancer cells and discusses its potential for manipulating tumor growth.
Cancer cells reprogram their metabolism to meet biosynthetic needs and to adapt to various microenvironments. Accelerated glycolysis offers proliferative benefits for malignant cells by generating glycolytic products that move into branched pathways to synthesize proteins, fatty acids, nucleotides, and lipids. Notably, reprogrammed glucose metabolism and its associated events support the hallmark features of cancer such as sustained cell proliferation, hijacked apoptosis, invasion, metastasis, and angiogenesis. Overproduced enzymes involved in the committed steps of glycolysis (hexokinase, phosphofructokinase-1, and pyruvate kinase) are promising pharmacological targets for cancer therapeutics. In this review, we summarize the role of reprogrammed glucose metabolism in cancer cells and how it can be manipulated for anti-cancer strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available